ArticleEJHaem2026

Real-World Outcomes of Thromboprophylaxis With Apixaban in Patients With Newly Diagnosed Multiple Myeloma, the MyelMeXa Study.

K Alexandra Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.